Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Lupin (company)

Tracked across 5 events · 50 articles · First seen Mar 20, 2025 · Last active Jul 06, 2026

Sentiment
64
Attention
6
Events
5
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Lupin (company) entered a licensing and supply agreement with Astec LifeSciences to co-market Semaglutide Injection in India, gaining semi-exclusive rights to distribute the drug under its own brand names. This enhances its diabetes portfolio and strengthens its commitment to advanced cardio-metabolic treatments.
Mar 17, 2026 · 7 articles
4 70
Business
Impact: Lupin (company) completed the acquisition of VISUfarma, significantly expanding its ophthalmology portfolio and strengthening its presence in Europe. This acquisition is expected to be immediately accretive and accelerate its specialty franchise build-out.
Apr 02, 2026 · 13 articles
4 70
Regulatory
Impact: Lupin (company) received tentative approval from the U.S. FDA for its Enzalutamide Tablets, which is a positive development for the company as it expands its product offerings and market reach.
Jun 26, 2026 · 16 articles
2 50
Business
Impact: Lupin (company) was recognized as one of the World's Most Sustainable Companies by TIME and Statista, highlighting its strong ESG performance and commitment to sustainability.
Jul 06, 2026 · 6 articles
6 60
Business
Impact: Lupin (company) is preparing to roll out generic semaglutide and has formed a licensing partnership with Astec LifeSciences, aiming to compete in the Indian weight-loss drug market.
Mar 20, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Lupin (company) live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.